Skip to content
Search

Latest Stories

Obesity drug could reduce heart attack risk, study finds

The trial, involving 17,604 patients, evaluated Wegovy not for weight loss but for its heart-protective benefits in overweight and obese individuals.

Obesity drug could reduce heart attack risk, study finds

An obesity drug has been found to decrease the risk of heart attacks, strokes, or heart failure in obese individuals regardless of the amount of weight they lose while on the medication, according to researchers.

The study of the drug, Wegovy, revealed that participants maintained significant weight loss over four years, with fewer serious adverse events compared to those given placebo treatment, reported Sky News.


These findings may prompt UK health authorities, which currently limit treatment to two years, to reconsider their policies.

The Danish drugmaker presented the new long-term data on Tuesday at the European Congress on Obesity in Venice, Italy, in a new analysis from a large study for which substantial results had been published last year, reported Reuters.

On average, participants lost 10.2 per cent of their body weight and 7.7 cm from their waist size after four years.

Even individuals with mild obesity or modest weight loss experienced cardiovascular benefits, suggesting potential broader effects of the treatment beyond fat reduction.

The study, led by Professor John Deanfield of University College London (UCL), utilised data from the Select trial conducted by Wegovy manufacturer Novo Nordisk.

Semaglutide, the active ingredient in Wegovy, belongs to a class of GLP-1 drugs that suppress appetite, aiding in calorie reduction.

The trial, involving 17,604 patients, evaluated Wegovy not for weight loss but for its heart-protective benefits in overweight and obese individuals with preexisting heart disease but without diabetes. Participants were not required to monitor diet and exercise as it was not focused on obesity, Reuters reported.

Around 17 per cent of trial participants discontinued Wegovy use due to side effects, primarily nausea, according to Novo's analysis.

Patients in the Select trial lost an average of nearly 10 per cent of their total body weight after 65 weeks on Wegovy. This weight loss was maintained year on year, reaching 10.2 per cent after approximately four years, as reported by the company.

Another analysis by Novo, also released on Tuesday, demonstrated that Wegovy's heart-protective benefits were consistent regardless of patients' initial weight or the amount of weight they lost on the drug.

"We now also understand that while we know that body weight loss is important, it's not the only thing driving the cardiovascular benefit of semaglutide treatment," Lange told Reuters in an interview.

The Select study revealed that Wegovy reduced the risk of major cardiovascular events such as strokes by 20 per cent in overweight or obese individuals with a history of heart disease. This news led to a 13 per cent surge in Novo shares to record highs upon its release in August.

Novo continues to investigate the mechanisms behind semaglutide's cardiovascular protection.

Wegovy and Zepbound are undergoing testing to evaluate their benefits in various medical conditions such as reducing heart attack risk, treating sleep apnea, and managing kidney disease.

More For You

Starmer

Starmer, who has faced negative coverage since taking office in July 2024, defended the appointment process.

Reuters

Starmer: I would not have appointed Mandelson if aware of Epstein ties

PRIME MINISTER Keir Starmer said on Monday he would not have appointed Peter Mandelson as UK ambassador to Washington had he known the extent of his links with convicted sex offender Jeffrey Epstein.

This was Starmer’s first public statement since dismissing Mandelson last week. The prime minister is facing questions over his judgement, including from Labour MPs, after initially standing by Mandelson before removing him from the post.

Keep ReadingShow less
Trump

Trump said the suspect had been arrested earlier for 'terrible crimes,' including child sex abuse, grand theft auto and false imprisonment, but was released under the Biden administration because Cuba refused to take him back.

Getty Images

Trump says accused in Dallas motel beheading will face first-degree murder charge

US PRESIDENT Donald Trump has described Chandra Mouli “Bob” Nagamallaiah, the Indian-origin motel manager killed in Dallas, as a “well-respected person” and said the accused will face a first-degree murder charge.

Nagamallaiah, 50, was killed last week at the Downtown Suites motel by co-worker Yordanis Cobos-Martinez, a 37-year-old undocumented Cuban immigrant with a criminal history.

Keep ReadingShow less
Starmer Mandelson

Starmer talks with Mandelson during a welcome reception at the ambassador's residence on February 26, 2025 in Washington, DC.

Getty

Starmer under pressure from party MPs after Mandelson dismissal

PRIME MINISTER Keir Starmer is facing questions within the Labour party after the sacking of US ambassador Peter Mandelson.

Mandelson was removed last week after Bloomberg published emails showing messages of support he sent following Jeffrey Epstein’s conviction for sex offences. The dismissal comes just ahead of US president Donald Trump’s state visit.

Keep ReadingShow less
Nepal’s new leader pledges to act on Gen Z calls to end corruption

Officials greet newly-elected Prime Minister of Nepal's interim government Sushila Karki (R) as she arrives at the prime minister's office in Kathmandu on September 14, 2025. (Photo by PRABIN RANABHAT/AFP via Getty Images)

Nepal’s new leader pledges to act on Gen Z calls to end corruption

NEPAL’s new interim prime minister Sushila Karki on Sunday (14) pledged to act on protesters’ calls to end corruption and restore trust in government, as the country struggles with the aftermath of its worst political unrest in decades.

“We have to work according to the thinking of the Gen Z generation,” Karki said in her first address to the nation since taking office on Friday (12). “What this group is demanding is the end of corruption, good governance and economic equality. We will not stay here more than six months in any situation. We will complete our responsibilities and hand over to the next parliament and ministers.”

Keep ReadingShow less
UK secures £1.25bn US investment ahead of Trump’s visit

US president Donald Trump and UK prime minister Sir Keir Starmer arrive at Trump International Golf Links on July 28, 2025 in Balmedie, Scotland. (Photo by Jane Barlow-WPA Pool/Getty Images)

UK secures £1.25bn US investment ahead of Trump’s visit

THE British government has announced over £1.25 billion ($1.69bn) in fresh investment from major US financial firms, including PayPal, Bank of America, Citigroup and S&P Global, ahead of a state visit by president Donald Trump.

The investment is expected to create 1,800 jobs across London, Edinburgh, Belfast and Manchester, and deepen transatlantic financial ties, the Department for Business and Trade said.

Keep ReadingShow less